Up a level |
Davis, Rebecca, McParland, Paula, Dodd, Susanna ORCID: 0000-0003-2851-3337, Storey, Daniel, Probert, Chris ORCID: 0000-0003-4550-0239, Collins, Paul, Skouras, Thomas, Steel, Alan, Derbyshire, Edmund, Dibb, Martyn et al (show 1 more authors)
(2019)
Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis.
European journal of gastroenterology & hepatology, 31 (6).
pp. 661-667.
Townsend, Tristan, Razanskaite, Violeta, Dodd, Susanna ORCID: 0000-0003-2851-3337, Storey, Daniel, Michail, Stephanie, Morgan, James, Davies, Michael, Penman, Douglas, Watters, Christopher, Swaminathan, Mira et al (show 7 more authors)
(2020)
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease.
Alimentary Pharmacology and Therapeutics, 52 (8).
pp. 1341-1352.
Smith, Philip, Critchley, Lisa, Storey, Daniel ORCID: 0000-0001-8101-8429, Gregg, Belle, Stenson, June, Kneebone, Andrew, Rimmer, Tracy, Burke, Stevena, Hussain, Shamas, Teoh, Wan Yi et al (show 10 more authors)
(2022)
EFFICACY AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS IFX (CT-P13): A MULTI-CENTRE COHORT STUDY.
In: Abstracts of the BSG Annual Meeting, 20–23 June 2022.
Smith, Philip J, Critchley, Lisa, Storey, Daniel, Gregg, Belle, Stenson, June, Kneebone, Andrew, Rimmer, Tracy, Burke, Stevena, Hussain, Shamas, Yi Teoh, Wan et al (show 10 more authors)
(2022)
Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study.
JOURNAL OF CROHNS & COLITIS, 16 (9).
pp. 1436-1446.
Lenti, Marco Vincenzo, Dolby, Vivien, Clark, Tanya, Hall, Veronica, Tattersall, Suzanne, Fairhurst, Francesca, Kenneth, Catherine, Walker, Rachael, Kemp, Karen, Borg-Bartolo, Simon et al (show 11 more authors)
(2022)
A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55 (7).
pp. 856-866.
Lenti, Marco Vincenzo, Levison, Scott, Eliadou, Elena, Willert, Robert, Kemp, Karen, Carter, Anna, Stansfield, Catherine, Assadsangabi, Arash, Singh, Salil, Crooks, Ben et al (show 13 more authors)
(2018)
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.
DIGESTIVE AND LIVER DISEASE, 50 (12).
pp. 1299-1304.